SENSUS HEALTHCARE, INC. (NASDAQ:SRTS) Files An 8-K Financial Statements and ExhibitsItem 9.01. Financial Statements and Exhibits.
|99.1||Press Release, dated September 21, 2018|
Sensus Healthcare, Inc. ExhibitEX-99.1 2 s112804_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Sensus Healthcare,…To view the full exhibit click
About SENSUS HEALTHCARE, INC. (NASDAQ:SRTS)
Sensus Healthcare, Inc., formerly Sensus Healthcare, LLC, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The superficial radiation therapy is an alternative to surgical basal cell carcinoma treatment and squamous cell carcinoma treatment. The Company’s product, the SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions, such as keloids. The SRT-100 treats primary lesions that would otherwise be difficult or require surgery involving sensitive areas of the head and neck regions, such as the fold in the nose, eyelids, lips, corner of the mouth and the lining of the ear.